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1. Introduction
Modern socioeconomic developments have generally resulted in a greatly improved quality 
of life for most, but these advances have been accompanied by the introduction of numerous 
health challenges arising from new diseases and casualties associated with environmental, 
industrial, and economical disasters, social and armed military clashes, occupational expo-
sures, daily high-speed traffic accidents, and so on. Among the diseases of growing public 
and military health concern is traumatic brain injury (TBI), which has been recently recog-
nized as a “silent epidemic” emerging globally at the transition of the twentieth and twenty-
first centuries [1–8].
2. Traumatic brain injury (TBI): definition, assessment and 
classification
Traumatic brain injury (TBI) can be defined as alteration in brain functions due to head col-
lision with a stationary or a moving object (e.g., a projectile) or upon coupling of an external 
mechanical force (e.g., g-force, blast shock wave (SW)) with the head [9–12]. The traumatic 
effects of these insults emerge as either open or closed head wounds yielding penetrating or 
closed TBI [11–14]. Clinical classification of TBI severity is widely achieved using the Glasgow 
Coma Scale (GCS)—a neurological scale designed to tally medical conditions of individuals in 
the disease sequelae. The severity of TBI can be classified as mild, moderate, severe, as well 
as vegetative state and brain death—estimated upon clinical presentation of a patient’s neu-
rologic signs and symptoms varying from case to case. Translational and clinical observations 
indicate that many symptoms resolve completely upon recovery, while others, especially 
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those resulting from “secondary injury” due to neurological complications and reactive trau-
matic responses to “primary trauma,” can persist as chronic illnesses resulting in partial or 
permanent disability [2, 3, 13, 15–18]. Consequently, TBI should not be regarded as a single 
clinical entity with a defined outcome but rather represents “a spectrum of brain injuries,” 
where each TBI subtype can lead to a distinct clinical condition which requires case-specific 
medical treatment [3]. From these considerations efficient personalized therapy would need 
implementation of advanced diagnostic techniques (such as contrast-enhanced computed 
tomography, diffusion tensor MRI, TBI biomarkers) for assessment of injury and monitoring 
of recovery (discussed in Chapters 1.5, 2.1, 2.2 of this book).
3. TBI: Etiology, pathobiology and translational research
Statistically, the vast majority of TBI is associated with vehicle collisions, damaging assaults, 
falls, collision/contact sports, and combat operations [4–11, 13]. These events initiate the pri-
mary mechanisms of blunt, ballistic, and blast-associated neurotrauma that may or may not 
be accompanied by skull fracture. Penetrating TBI is readily apparent and generates dam-
age localized along the projectile path through the brain that includes a site of fractured or 
perforated skull, ruptured meninges, and lesions of the brain tissue [13, 19]. The absence of 
such conspicuous hallmarks in closed TBI can result in an initial underestimation of injury 
severity, particularly when a TBI score is “mild” [12]. In situations producing blunt closed 
TBI, the damaging forces to the head induce an intracranial inertial force due to linear accel-
eration/deceleration or rotational momentum to the brain, so it collides inside with the skull 
resulting in focal “coup or contrecoup or rotational shearing injuries” [12, 20, 21]. Moreover, 
the same external forces to the skull can generate an array of tensor stress forces (e.g., normal 
and shear, tensile) through the brain tissue that cause cell compression/stretching, disorder 
axonal trafficking (i.e., axoplasmic transport of mitochondria, synaptic vesicles, proteins, etc., 
from neuron’s body through the axoplasm), and yet shear and fraction neuronal fibers and 
disrupt the microvasculature and meningeal structures, thus leading to different forms of 
intracranial hemorrhage [13, 18, 20, 22–28]. The disruption and dismantling of brain circuitry 
by these mechanical forces are the principal effectors of injury [20, 25]. Primary brain contu-
sions can elicit concussions, diffuse axonal injury (DAI) and encephalopathy, dysregulation of 
intracranial pressure and the flow of cerebrospinal fluid (CSF), and the impairment of visceral 
organs and systems complicated by a variety of neurochemical and metabolic effects [12, 20, 
21, 26, 27]. From an etiological perspective, the secondary injury factors can feature brain 
ischemia and hypoxia, hypercapnia, neuroinflammation, impairment of blood-brain barrier, 
cerebral edema, meningitis, seizures, and so on [12–17, 21, 25].
A devastating form of TBI is produced by shock waves generated by detonation of explosive 
devices [7, 11, 12]. At the center of the explosion, gaseous products instantaneously expand 
from a small volume at a very high-pressure state through the surrounding ambient pressure 
environment. The compressed gases expand outwards at a supersonic speed in a form of air 
shock wave (SW). When encountering the head, the SW can impart energy to skull bones, 
dura and arachnoid mater, CSF, and neuronal tissue through which energy is delivered and 
dissipated via different mechanisms, namely inertia, spalling, shearing, compression, and 
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cerebral air embolism. A combination of DAI, meningitis, brain edema, ischemia, and neuro-
cognitive disorders accompanied by systemic organ system complications are the described 
features of blast TBI and reflect the multifactorial nature of SW effects [12, 21, 23, 28].
The pathogenesis and recoveries from these varieties of TBI are age- and phenotype-depen-
dent, greatly adding to the complexities and challenges for the development of therapies 
[29–31]. A recent focus in translational research has been the roles of genetic and epigenetic 
polymorphism in TBI disease, giving new perspectives on TBI management and identification 
of potential targets for rehabilitation [30–32]. This translational research has been primarily 
driven by animal models that have been developed over the past decades to mimic the clinical 
sequelae of human TBI. As noted earlier, since human TBI is very heterogeneous, no single 
animal model suffices, and researchers have relied upon the use of distinct yet complemen-
tary models to capture the characteristic features of human TBI documented through clini-
cal and postmortem examination. As extensively reviewed [23 34–36], although imperfect, 
these in vivo and in vitro models together have provided valuable insights into posttraumatic 
sequelae which can be targeted for therapeutic intervention. Nevertheless, the failure to date 
to successfully translate a neuroprotective drug through phase 2 and 3 clinical trials high-
lights the compelling need to improve models to achieve an ecological validity and a greater 
translational value.
4. Epidemiology and social impact of TBI-related diseases
The epidemiology of TBI is overwhelming worldwide. According to the U.S. Department of 
Health and Human Services, in the United States, the overall incidence of TBI (either as an iso-
lated injury or in combination with other injuries (i.e., polytrauma)) in 2010 was estimated to 
be 823.7 per 100,000 population, and the cost for direct TBI medical care in U.S. was estimated 
at more than $50 billion per year [4]. A lower TBI rate was reported in Europe (235 per 100,000) 
in 2006 [5]. It should be noted that the above numbers in U.S. did not account for those per-
sons who received care at the U.S. military or Veterans Affairs hospitals [6]. According to the 
U.S. Department of Defense report of 2013, the cohort of servicemen diagnosed with a TBI 
from 2000 through 2011 represented 235,046 persons (or 4.2% of the 5,603,720 who served 
in the Army, Air Force, Navy, and Marine Corps) (http://dvbic.dcoe.mil/dod-worldwide-
numbers-tbi) [7, 11, 33]. Overall, among TBI casualties, almost 100% of persons with severe 
head injury and over 50% of those with moderate head injury acquire permanent disability 
and will not return to their premorbid level of function, which creates a major socioeconomic 
burden [4, 5, 9, 33]. In addition, dramatic psychological changes can occur among the TBI 
survivors who experience “the invisible injuries” of brain trauma (e.g., posttraumatic stress 
disorder (PTSD)). These occult injuries are particularly challenging, since the changes occur 
in the absence of any outward manifestation of injury and alterations in patient appearance, 
making diagnosis, management, and prognosis extremely difficult.
In the global perspective, the recent continuous expansion of military conflicts in the Middle 
East, Afghanistan, and North Africa occurs with the implementation of enormous amounts of 
weaponized conventional explosives which when deployed and detonated inevitably affect 
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civilian populations in the conflict zones. The bTBI civilian casualties due to these proxy wars 
are poorly determined [8]. Considering massive migration of civilian populations driven by 
these disasters to Europe, the bTBI epidemiology in these groups requires a particular atten-
tion, since their social care is becoming a burden of host countries.
5. Conclusion
TBI disease remains a continually growing public health concern both domestically and 
globally and has taken on a heightened urgency with the recent recognition of a grow-
ing number of chronic traumatic encephalopathy victims among athletes and Warfighters 
exposed to repetitive sub-concussive insults [37–39]. Although a daunting problem, con-
siderable progress has been made over the past decade with characterizations of TBI 
etiology, epidemiology, and advances in definitions of age- and genotype-specific patho-
biology/pathophysiology, diagnostics, acute medical-surgical treatments (e.g., prevention 
of secondary injuries and maintenance of brain physiology), as well as on the develop-
ment of new modalities for long-term targeted therapy, rehabilitative care, and TBI pre-
vention (see Chapters 1.1–2.5 of this book). Despite significantly reduced TBI mortality 
rates at surgical emergency and acute treatments, improvements in long-term outcomes 
remain a great challenge, largely because as noted earlier, the disease does not represent 
one pathological entity but is rather a syndrome represented by a wide range of lesions 
that can require different patient-specific therapies in order to sustain neurological and 
physiological recovery. Further resolution of these problems requires a mutual effort of 
clinicians/surgeons, biomedical scientists, biotechnologists, pharmacologists, and bio-
medical engineers.
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